["Adaptation of the tumour and its ecosystem to radiotherapies: Mechanisms, imaging and therapeutic approaches" XIVth edition of the workshop organised by the "Vectorisation, Imagerie, Radiothérapies" network of the Cancéropôle Grand-Ouest, 22-25 September 2021, Le Bono, France].

« Adaptation of the tumour and its ecosystem to radiotherapies: Mechanisms, imaging and therapeutic approaches » XIV
External beam radiotherapy Imagerie Imaging Molecular radiotherapy Radiothérapie externe Radiothérapie interne Tumor ecosystem Écosystème tumoral

Journal

Bulletin du cancer
ISSN: 1769-6917
Titre abrégé: Bull Cancer
Pays: France
ID NLM: 0072416

Informations de publication

Date de publication:
Oct 2022
Historique:
received: 21 03 2022
revised: 03 06 2022
accepted: 07 06 2022
pubmed: 1 8 2022
medline: 12 10 2022
entrez: 31 7 2022
Statut: ppublish

Résumé

The fourteenth edition of the workshop covered the latest advances in internal and external radiotherapy obtained through a better understanding of the adaptive capacity of the tumor and its microenvironment, from different disciplinary angles, chemistry, biology, physics, and medicine, paving the way for numerous technological innovations. The biological aspects and the contribution of imaging in monitoring and understanding the adaptation of tumors to radiotherapy were presented, before focusing on innovative radiotherapy strategies and machine learning and data-driven techniques. Finally, the challenges were explored in the radiobiology of targeted radionuclide therapy as well as data science and machine learning in radiomics.

Identifiants

pubmed: 35908990
pii: S0007-4551(22)00271-5
doi: 10.1016/j.bulcan.2022.06.005
pii:
doi:

Substances chimiques

Radioisotopes 0

Types de publication

Clinical Conference

Langues

fre

Sous-ensembles de citation

IM

Pagination

1088-1093

Informations de copyright

Copyright © 2022.

Auteurs

Françoise Léost (F)

Cancéropôle Grand-Ouest, IRS-UN, 8, quai Moncousu, 44007 Nantes cedex 1, France. Electronic address: Francoise.leost@univ-nantes.fr.

Grégory Delpon (G)

Institut de Cancérologie de l'Ouest, département de physique médicale, boulevard Jacques-Monod, 44800 Nantes Saint-Herblain, France.

Emmanuel Garcion (E)

Université d'Angers, Nantes université, Inserm UMR 1307, CNRS UMR 6075, CRCI2NA, 49000 Angers, France.

Jean-François Gestin (JF)

Nantes Université, université d'Angers, Inserm UMR 1307, CNRS UMR 6075, CRCI2NA, 44000 Nantes, France.

Mathieu Hatt (M)

LaTIM, Inserm, UMR 1101, IBSAM, UBO, UBL, 22, rue Camille-Desmoulins, 29238 Brest, France.

Vincent Potiron (V)

Institut de cancérologie de l'Ouest, département de radiothérapie, boulevard Jacques-Monod, 44800 Nantes Saint-Herblain, France.

Latifa Rbah-Vidal (L)

Nantes Université, université d'Angers, Inserm UMR 1307, CNRS UMR 6075, CRCI2NA, 44000 Nantes, France.

Stéphane Supiot (S)

Institut de cancérologie de l'Ouest, département de radiothérapie, boulevard Jacques-Monod, 44800 Nantes Saint-Herblain, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH